Radiol Clin North Am 2001 Sep;39(5):871-81
Positron emission tomography: brain tumors and lung cancer.
Hagge RJ, Wong TZ, Coleman RE.
F-18 fluorodeoxyglucose positron emission tomography is a uniquely powerful
diagnostic tool that noninvasively provides information that is critical to
appropriate clinical management of patients with non-small cell lung cancer. Not
only does the functional information provided by PET complement and clarify the
anatomic information supplied by CT and MR imaging, but the superior sensitivity
and negative predictive value of PET allow for improved accuracy in diagnosis,
prognosis, staging, and monitoring the effects of treatment. With better
information at their disposal, clinicians and patients are able to make
better-informed decisions, contributing to more appropriate and more
cost-effective medical care. Truly, FDG-PET has earned its place as the new
standard of care in imaging non-small cell lung cancer.
